Franck Chiappini

Franck Chiappini currently serves as the Head of Scientific Projects at OTR3, overseeing research and development initiatives related to ReGenerAting Therapy (RGTA) utilizing glycosaminoglycan mimetics for extracellular matrix reconstruction. Additionally, Franck is a Postdoctoral Fellow at Beth Israel Deaconess Medical Center affiliated with Harvard Medical School, contributing to IACUC and mentoring roles. Previous experience includes Senior Research Scientist and Research Administrative Manager at Centre HépatoBiliaire-InsermU1193 and a post-doctoral fellowship focused on lipid identification in chronic liver conditions at Hôpital Paul Brousse. Franck's academic background includes a DVM in Veterinary Medicine from Ecole nationale vétérinaire de Lyon and postdoctoral research in Neurobiology and Neurosciences at Harvard Medical School.